Published in Am J Epidemiol on November 14, 2006
Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care (2013) 1.99
Gait speed predicts decline in attention and psychomotor speed in older adults: the health aging and body composition study. Neuroepidemiology (2007) 1.68
Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care (2012) 1.51
Measuring cognitive change in subjects with prodromal Alzheimer's disease. J Neurol Neurosurg Psychiatry (2013) 1.48
Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia. JAMA (2010) 1.35
Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study. Am J Psychiatry (2012) 1.00
Misuse of the linear mixed model when evaluating risk factors of cognitive decline. Am J Epidemiol (2011) 0.98
Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease. BMC Psychol (2013) 0.98
Patterns of cognitive performance in healthy ageing in Northern Portugal: a cross-sectional analysis. PLoS One (2011) 0.97
Latent variables and structural equation models for longitudinal relationships: an illustration in nutritional epidemiology. BMC Med Res Methodol (2010) 0.95
Albuminuria and cognitive decline in people with diabetes and normal renal function. Clin J Am Soc Nephrol (2013) 0.95
Olive oil and cognition: results from the three-city study. Dement Geriatr Cogn Disord (2009) 0.86
Occupational exposure to solvents and cognitive performance in the GAZEL cohort: preliminary results. Dement Geriatr Cogn Disord (2010) 0.85
Sex differences in cognitive trajectories in clinically normal older adults. Psychol Aging (2016) 0.83
Statins and their effect on cognition: Let's clear up the confusion. Can Pharm J (Ott) (2015) 0.83
Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study. Mol Psychiatry (2015) 0.82
Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets. Neuroepidemiology (2014) 0.82
Association of blood cotinine level with cognitive and physical performance in non-smoking older adults. Environ Res (2012) 0.81
Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study. PLoS Med (2017) 0.79
Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND. J Diabetes Complications (2013) 0.78
Impact of missing data on analysis of postoperative cognitive decline (POCD). Appl Nurs Res (2013) 0.75
Biomarkers of Exposure to Polycyclic Aromatic Hydrocarbons and Cognitive Function among Elderly in the United States (National Health and Nutrition Examination Survey: 2001-2002). PLoS One (2016) 0.75
An approach for estimating item sensitivity to within-person change over time: An illustration using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog). Psychol Assess (2016) 0.75
Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) - a Pan Canadian cohort study. BMC Public Health (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Random-effects models for longitudinal data. Biometrics (1982) 54.17
The processing-speed theory of adult age differences in cognition. Psychol Rev (1996) 15.76
The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32
The Set test as an aid to the detection of dementia in old people. Br J Psychiatry (1973) 3.52
A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med (2000) 2.90
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain (2005) 2.51
A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. Am J Epidemiol (1997) 2.50
Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol (1994) 1.96
Measuring cognitive change in a cohort of patients with Alzheimer's disease. Stat Med (2000) 1.30
Methodological issues in the study of cognitive decline. Am J Epidemiol (1999) 1.28
A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data. Biometrics (2006) 1.12
Cognitive predictors of dementia in elderly community residents. Neuroepidemiology (1997) 1.06
Statistical description of the Mini-Mental State Examination for French elderly community residents. Paquid Study Group. J Nerv Ment Dis (1992) 0.87
On the importance of longitudinal research in Alzheimer's disease. J Am Geriatr Soc (1991) 0.87
[Analysis of longitudinal Gaussian data with missing data on the response variable]. Rev Epidemiol Sante Publique (1999) 0.82
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Benzodiazepine use and risk of dementia: prospective population based study. BMJ (2012) 4.32
Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol (2008) 4.07
Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA (2009) 4.01
Relationship between blood pressure and outdoor temperature in a large sample of elderly individuals: the Three-City study. Arch Intern Med (2009) 3.38
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol (2012) 2.65
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain (2005) 2.51
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med (2009) 2.41
Mixed models for longitudinal left-censored repeated measures. Comput Methods Programs Biomed (2004) 2.23
Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med (2012) 2.16
Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc (2009) 1.87
Bivariate linear mixed models using SAS proc MIXED. Comput Methods Programs Biomed (2002) 1.87
Do subject characteristics modify the effects of particulate air pollution on daily mortality among the elderly? J Occup Environ Med (2004) 1.82
Relationship between blood pressure and depression in the elderly. The Three-City Study. J Hypertens (2008) 1.79
Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study. J Am Geriatr Soc (2007) 1.75
Frailty among community-dwelling elderly people in France: the three-city study. J Gerontol A Biol Sci Med Sci (2008) 1.70
Fish, meat, and risk of dementia: cohort study. BMJ (2002) 1.66
Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol (2003) 1.65
Is there a link between open-angle glaucoma and dementia? The Three-City-Alienor cohort. Ann Neurol (2013) 1.60
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care (2008) 1.52
Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort. BMC Geriatr (2009) 1.50
Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol (2005) 1.48
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med (2013) 1.48
Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr (2008) 1.45
Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort. Neurology (2012) 1.44
The severity of urinary incontinence decreases health-related quality of life among community-dwelling elderly. J Gerontol A Biol Sci Med Sci (2012) 1.44
Normalized Mini-Mental State Examination for assessing cognitive change in population-based brain aging studies. Neuroepidemiology (2014) 1.39
Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study. Stroke (2009) 1.38
Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events. Biostatistics (2007) 1.38
Joint latent class models for longitudinal and time-to-event data: a review. Stat Methods Med Res (2012) 1.34
Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens (2006) 1.34
Prevalence and description of chronic daily headache in the general population in France. Pain (2003) 1.33
Effects of particulate air pollution on systolic blood pressure: A population-based approach. Environ Res (2006) 1.30
Insomnia symptoms in older adults: associated factors and gender differences. Am J Geriatr Psychiatry (2011) 1.28
Random change point model for joint modeling of cognitive decline and dementia. Biometrics (2006) 1.27
Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord (2004) 1.20
A nonlinear latent class model for joint analysis of multivariate longitudinal data and a binary outcome. Stat Med (2007) 1.20
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf (2009) 1.20
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Prevalence of refractive error in Europe: the European Eye Epidemiology (E(3)) Consortium. Eur J Epidemiol (2015) 1.18
Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One (2008) 1.17
Cognitive disorders in HIV-infected patients: are they HIV-related? AIDS (2013) 1.14
A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data. Biometrics (2006) 1.12
Influence of education on the pattern of cognitive deterioration in AD patients: the cognitive reserve hypothesis. Brain Cogn (2005) 1.11
Late-life depression and mortality: influence of gender and antidepressant use. Br J Psychiatry (2008) 1.10
Incidence of central nervous system tumors in Gironde, France. Neuroepidemiology (2004) 1.09
Estimation of dynamical model parameters taking into account undetectable marker values. BMC Med Res Methodol (2006) 1.08
Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline. Brain (2014) 1.08
Education, occupation, leisure activities, and brain reserve: a population-based study. Neurobiol Aging (2010) 1.07
Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arterioscler Thromb Vasc Biol (2011) 1.05
Distension of the carotid artery and risk of coronary events: the three-city study. Arterioscler Thromb Vasc Biol (2008) 1.04
What aspects of social network are protective for dementia? Not the quantity but the quality of social interactions is protective up to 15 years later. Psychosom Med (2010) 1.04
Association between Parkinson's disease and exposure to pesticides in southwestern France. Neuroepidemiology (2003) 1.03
Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur J Clin Pharmacol (2004) 1.03
Cognitive impairment and dementia in elderly people living in rural Benin, west Africa. Dement Geriatr Cogn Disord (2009) 1.02
Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community. Dement Geriatr Cogn Disord (2007) 1.02
French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. Am J Clin Nutr (2011) 1.01
Gender and education impact on brain aging: a general cognitive factor approach. Psychol Aging (2008) 1.01
Prevalence of dementia in elderly living in two cities of Central Africa: the EDAC survey. Dement Geriatr Cogn Disord (2010) 1.01
Alcohol consumption and carotid artery structure in older French adults: the Three-City Study. Stroke (2004) 0.99
Misuse of the linear mixed model when evaluating risk factors of cognitive decline. Am J Epidemiol (2011) 0.98
Clustering and switching processes in semantic verbal fluency in the course of Alzheimer's disease subjects: results from the PAQUID longitudinal study. Cortex (2007) 0.98
Cardiovascular mortality and calcium and magnesium in drinking water: an ecological study in elderly people. Eur J Epidemiol (2003) 0.98
Driving cessation and self-reported car crashes in older drivers: the impact of cognitive impairment and dementia in a population-based study. J Geriatr Psychiatry Neurol (2008) 0.96
High concentrations of plasma n3 fatty acids are associated with decreased risk for late age-related macular degeneration. J Nutr (2013) 0.95
Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol (2008) 0.95
Influence of retirement and work stress on headache prevalence: a longitudinal modelling study from the GAZEL Cohort Study. Cephalalgia (2011) 0.93
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimers Dement (2009) 0.93
Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study. Pharmacoeconomics (2004) 0.92
Ten-year change in disability prevalence and related factors in two generations of French elderly community dwellers: data from the PAQUID study. Aging Clin Exp Res (2005) 0.92
Calf circumference is inversely associated with carotid plaques. Stroke (2008) 0.91
Factors associated with morbidity during the 2003 heat wave in two population-based cohorts of elderly subjects: PAQUID and Three City. Eur J Epidemiol (2008) 0.91
Associations of complement factor H and smoking with early age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci (2011) 0.90
Gender differences in the prodromal signs of dementia: memory complaint and IADL-restriction. a prospective population-based cohort. J Alzheimers Dis (2011) 0.90
Depression history, depressive symptoms, and incident dementia: the 3C Study. J Alzheimers Dis (2011) 0.89
Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients. Alzheimer Dis Assoc Disord (2008) 0.89
Distinctive alterations of the cingulum bundle during aging and Alzheimer's disease. Neurobiol Aging (2008) 0.89
A longitudinal study of quantitative and qualitative features of category verbal fluency in incident Alzheimer's disease subjects: results from the PAQUID study. Dement Geriatr Cogn Disord (2006) 0.89
A subtest of the MMSE as a valid test of episodic memory? Comparison with the Free and Cued Reminding Test. Dement Geriatr Cogn Disord (2009) 0.89